Peapack-Gladstone Financial Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2M | Sell |
879,706
-5,746
| -0.6% | -$150K | 0.24% | 102 |
|
|
2026
Q1 | $24.9M | Buy |
885,452
+18,749
| +2% | +$499K | 0.32% | 89 |
|
|
2025
Q4 | $21.6M | Buy |
866,703
+161,386
| +23% | +$4.07M | 0.27% | 95 |
|
|
2025
Q3 | $18M | Sell |
705,317
-39,013
| -5% | -$963K | 0.23% | 106 |
|
|
2025
Q2 | $18M | Buy |
744,330
+29,417
| +4% | +$686K | 0.26% | 99 |
|
|
2025
Q1 | $18.1M | Sell |
714,913
-20,052
| -3% | -$525K | 0.27% | 96 |
|
|
2024
Q4 | $19.5M | Sell |
734,965
-28,011
| -4% | -$760K | 0.28% | 95 |
|
|
2024
Q3 | $22.1M | Buy |
762,976
+147,405
| +24% | +$4.3M | 0.32% | 88 |
|
|
2024
Q2 | $17.2M | Buy |
615,571
+30,498
| +5% | +$840K | 0.26% | 98 |
|
|
2024
Q1 | $16.2M | Sell |
585,073
-7,641
| -1% | -$212K | 0.25% | 105 |
|
|
2023
Q4 | $17.1M | Buy |
592,714
+71,514
| +14% | +$2.16M | 0.29% | 95 |
|
|
2023
Q3 | $17.3M | Sell |
521,200
-15,766
| -3% | -$558K | 0.32% | 86 |
|
|
2023
Q2 | $19.7M | Sell |
536,966
-963
| -0.2% | -$37.5K | 0.35% | 79 |
|
|
2023
Q1 | $22.6M | Sell |
537,929
-12,362
| -2% | -$534K | 0.43% | 68 |
|
|
2022
Q4 | $28.2M | Sell |
550,291
-20,854
| -4% | -$1,000K | 0.56% | 49 |
|
|
2022
Q3 | $25M | Buy |
571,145
+71,198
| +14% | +$3.46M | 0.51% | 59 |
|
|
2022
Q2 | $26.2M | Buy |
499,947
+11,853
| +2% | +$604K | 0.6% | 51 |
|
|
2022
Q1 | $25.3M | Sell |
488,094
-239
| -0% | -$12.4K | 0.5% | 59 |
|
|
2021
Q4 | $28.8M | Sell |
488,333
-28
| -0% | -$1.39K | 0.54% | 54 |
|
|
2021
Q3 | $21M | Buy |
488,361
+66,192
| +16% | +$2.93M | 0.43% | 64 |
|
|
2021
Q2 | $16.5M | Sell |
422,169
-2,333
| -0.5% | -$90.7K | 0.4% | 74 |
|
|
2021
Q1 | $15.4M | Buy |
424,502
+103,315
| +32% | +$3.67M | 0.4% | 73 |
|
|
2020
Q4 | $11.8M | Buy |
321,187
+19,078
| +6% | +$700K | 0.35% | 83 |
|
|
2020
Q3 | $10.5M | Buy |
302,109
+21,702
| +8% | +$761K | 0.38% | 77 |
|
|
2020
Q2 | $8.7M | Buy |
280,407
+4,226
| +2% | +$144K | 0.34% | 83 |
|
|
2020
Q1 | $8.55M | Buy |
276,181
+8,844
| +3% | +$301K | 0.4% | 71 |
|
|
2019
Q4 | $9.94M | Sell |
267,337
-3,838
| -1% | -$137K | 0.4% | 75 |
|
|
2019
Q3 | $9.24M | Sell |
271,175
-6,580
| -2% | -$239K | 0.4% | 75 |
|
|
2019
Q2 | $11.4M | Buy |
277,755
+19,725
| +8% | +$783K | 0.49% | 61 |
|
|
2019
Q1 | $10.4M | Buy |
258,030
+194
| +0.1% | +$7.77K | 0.47% | 67 |
|
|
2018
Q4 | $10.7M | Buy |
257,836
+4,553
| +2% | +$189K | 0.55% | 59 |
|
|
2018
Q3 | $10.6M | Buy |
253,283
+4,331
| +2% | +$167K | 0.52% | 68 |
|
|
2018
Q2 | $8.57M | Buy |
248,952
+8,483
| +4% | +$290K | 0.45% | 74 |
|
|
2018
Q1 | $8.1M | Buy |
240,469
+3,256
| +1% | +$112K | 0.44% | 75 |
|
|
2017
Q4 | $8.15M | Buy |
237,213
+22,759
| +11% | +$776K | 0.44% | 77 |
|
|
2017
Q3 | $7.26M | Buy |
214,454
+4,179
| +2% | +$134K | 0.42% | 79 |
|
|
2017
Q2 | $6.7M | Buy |
210,275
+7,864
| +4% | +$248K | 0.4% | 84 |
|
|
2017
Q1 | $6.57M | Buy |
202,411
+25,244
| +14% | +$796K | 0.4% | 83 |
|
|
2016
Q4 | $5.46M | Buy |
177,167
+13,491
| +8% | +$412K | 0.35% | 86 |
|
|
2016
Q3 | $5.26M | Buy |
163,676
+6,820
| +4% | +$228K | 0.35% | 86 |
|
|
2016
Q2 | $5.24M | Buy |
156,856
+9,783
| +7% | +$312K | 0.36% | 87 |
|
|
2016
Q1 | $4.14M | Sell |
147,073
-1,593
| -1% | -$45.5K | 0.29% | 93 |
|
|
2015
Q4 | $4.55M | Sell |
148,666
-1,635
| -1% | -$51.4K | 0.32% | 95 |
|
|
2015
Q3 | $4.48M | Buy |
150,301
+3,220
| +2% | +$103K | 0.34% | 88 |
|
|
2015
Q2 | $4.68M | Buy |
147,081
+8,114
| +6% | +$264K | 0.33% | 89 |
|
|
2015
Q1 | $4.59M | Buy |
138,967
+704
| +0.5% | +$22.4K | 0.32% | 90 |
|
|
2014
Q4 | $4.09M | Buy |
138,263
+5,560
| +4% | +$159K | 0.29% | 97 |
|
|
2014
Q3 | $3.72M | Sell |
132,703
-13,173
| -9% | -$370K | 0.28% | 101 |
|
|
2014
Q2 | $4.11M | Sell |
145,876
-1,107
| -0.8% | -$31.6K | 0.31% | 89 |
|
|
2014
Q1 | $4.48M | Sell |
146,983
-2,791
| -2% | -$83.2K | 0.35% | 82 |
|
|
2013
Q4 | $4.35M | Buy |
149,774
+16,135
| +12% | +$470K | 0.35% | 83 |
|
|
2013
Q3 | $3.64M | Sell |
133,639
-9,761
| -7% | -$266K | 0.32% | 86 |
|
|
2013
Q2 | $3.81M | Buy |
+143,400
| New | +$3.96M | 0.35% | 79 |
|
Other funds holding PFE
Peapack-Gladstone Financial Corp's PFE Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp reduced its Pfizer (PFE) stake by 0.65% in Q2 2026, selling an estimated $150K and leaving 879,706 shares worth $21.2M. The position accounts for 0.24% of the portfolio, ranked #102.
Peapack-Gladstone Financial Corp first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.8M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Peapack-Gladstone Financial Corp held 879,706 shares of Pfizer worth $21.2M as of Q2 2026.
- Peapack-Gladstone Financial Corp sold 5,746 Pfizer shares in Q2 2026, an estimated $150K.
- Pfizer made up 0.24% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #102 holding.
- Peapack-Gladstone Financial Corp first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Peapack-Gladstone Financial Corp's Pfizer position peaked at $28.8M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.